📰 Life Sciences Group News
Page 2 - Life Sciences Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Life Sciences Group. Real-time updates on events, politics, business and more.
January 4, 2024
By Colin Kellaher Shares of SELLAS Life Sciences Group tumbled nearly 30% in premarket trading Thursday after the clinical-stage biopharmaceutical company...
December 21, 2023
David Wolf to move to Executive ChairmanBEVERLY, Mass. and TORONTO, Dec. 21, 2023 -- Hamilton Thorne Ltd. , a leading provider of precision instruments, consumables, software and services to the...
December 19, 2023
Two dozen companies and trade names are connected to O.P.M.S. Many are cloaked in secrecy.
December 14, 2023
SELLAS Life Sciences Group (NASDAQ:SLS – Get Free Report) and Imunon (NASDAQ:IMNN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations. Risk and Volatility SELLAS Life Sciences […]
December 6, 2023
/PRNewswire/ -- Burns & Levinson announced today that partner Robert Petitt has been named Co-Chair of the firms Securities and Capital Markets Practice Group....
November 30, 2023
Investegate announcements from Placing and Subscription
November 16, 2023
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS – Free Report) – Investment analysts at Cantor Fitzgerald lowered their FY2023 earnings per share estimates for SELLAS Life Sciences Group in a research report issued to clients and investors on Monday, November 13th. Cantor Fitzgerald analyst L. Watsek now forecasts that the company will post earnings of ($1.04) […]
November 13, 2023
By Chris Wack Sellas Life Sciences Group has received favorable Type C meeting feedback from the Food and Drug Administration for its lead product, galinpepimut-S. The recently concluded...
October 31, 2023
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The
October 31, 2023
By Chris Wack Sellas Life Sciences Group shares were down 10% to $1.04 after the company entered into a securities purchase agreement with a single,...